Resveratrol attenuated TNF-α–induced MMP-3 expression in human nucleus pulposus cells by activating autophagy via AMPK/SIRT1 signaling pathway
暂无分享,去创建一个
Lei Liu | Xin Hong | Xiaohu Wang | Lei Zhu | Xiao-Tao Wu | Feng Wang | Xiao-Tao Wu | Xiao-Hu Wang | Lei Zhu | Yun-Tao Wang | Feng Wang | Jun-Ping Bao | Xin-Hui Xie | Xin Hong | Xinhui Xie | Lei Liu | Yun-tao Wang | Junping Bao
[1] G. Waddell. Low Back Pain: A Twentieth Century Health Care Enigma , 1996, Spine.
[2] W. Yong,et al. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. , 2008, Biochemical and biophysical research communications.
[3] S. Hukuda,et al. Immunohistochemical Study of Matrix Metalloproteinase‐3 and Tissue Inhibitor of Metalloproteinase‐1 in Human Intervertebral Discs , 1996, Spine.
[4] K. Mills,et al. Autophagy and inflammatory diseases , 2013, Immunology and cell biology.
[5] SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway , 2013, AGE.
[6] Jing Sun,et al. Resveratrol Inhibits Enterovirus 71 Replication and Pro-Inflammatory Cytokine Secretion in Rhabdosarcoma Cells through Blocking IKKs/NF-κB Signaling Pathway , 2015, PloS one.
[7] M. Englund,et al. Low back pain: Epidemiology of consultations , 2012, Arthritis care & research.
[8] Xiaohu Wang,et al. Tumor necrosis factor alpha promotes the proliferation of human nucleus pulposus cells via nuclear factor-κB, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase , 2015, Experimental biology and medicine.
[9] James D. Kang,et al. p38 MAPK inhibition modulates rabbit nucleus pulposus cell response to IL‐1 , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[10] Y. Turkoz,et al. Effect of resveratrol in experimental osteoarthritis in rabbits , 2005, Inflammation Research.
[11] James D. Kang,et al. Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications. , 2001, The spine journal : official journal of the North American Spine Society.
[12] I. Villegas,et al. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. , 2005, Molecular nutrition & food research.
[13] Robert Clarke,et al. Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .
[14] N. Boos,et al. Expression and Distribution of Tumor Necrosis Factor Alpha in Human Lumbar Intervertebral Discs: A Study in Surgical Specimen and Autopsy Controls , 2005, Spine.
[15] S. Emr,et al. Autophagy as a regulated pathway of cellular degradation. , 2000, Science.
[16] Chibuike C. Udenigwe,et al. Potential of resveratrol in anticancer and anti-inflammatory therapy. , 2008, Nutrition reviews.
[17] M. V. van Tulder,et al. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specific). , 2007, Best practice & research. Clinical rheumatology.
[18] P. Puigserver,et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.
[19] Joon Ho Wang,et al. Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. , 2009, Clinical biochemistry.
[20] DJ Klinonsky. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd Ed.) , 2016 .
[21] Wei-Kang Wu,et al. Resveratrol Protects HUVECs from Oxidized-LDL Induced Oxidative Damage by Autophagy Upregulation via the AMPK/SIRT1 Pathway , 2013, Cardiovascular Drugs and Therapy.
[22] P. Roughley,et al. Tumor Necrosis Factor&agr; Modulates Matrix Production and Catabolism in Nucleus Pulposus Tissue , 2005, Spine.
[23] J. Iatridis,et al. A role for TNFα in intervertebral disc degeneration: a non-recoverable catabolic shift. , 2013, Biochemical and biophysical research communications.
[24] A. Freemont,et al. Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration , 2009, Arthritis research & therapy.
[25] M. Tulder,et al. Low back pain (non-specific) , 2007 .
[26] Jang-Gi Choi,et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. , 2009, Pharmacological research.
[27] Z. Werb,et al. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. , 1985, The Journal of biological chemistry.
[28] R. Quirion,et al. Neuroprotective action of resveratrol. , 2015, Biochimica et biophysica acta.
[29] J. Enghild,et al. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. , 1992, The Journal of biological chemistry.
[30] H. Haro,et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. , 2001, The Journal of bone and joint surgery. British volume.
[31] I. Shapiro,et al. Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-κB. , 2013, The American journal of pathology.
[32] P. Stephens,et al. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. , 1987, The Biochemical journal.
[33] R. S. Lee,et al. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. , 2000, Cardiovascular research.
[34] Jinwei Chen,et al. Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway , 2013, Rheumatology International.
[35] D. Eyre,et al. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. , 1991, The Journal of biological chemistry.
[36] N. Elmalı,et al. Effects of Resveratrol in Inflammatory Arthritis , 2007, Inflammation.
[37] C. Gonçalves,et al. Resveratrol Protects Hippocampal Astrocytes Against LPS-Induced Neurotoxicity Through HO-1, p38 and ERK Pathways , 2015, Neurochemical Research.
[38] Jang-Gi Choi,et al. Anti-inflammatory effect of resveratrol by inhibition of IL-8 production in LPS-induced THP-1 cells. , 2009, The American journal of Chinese medicine.
[39] André Quincozes-Santos,et al. Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.
[40] Xiaoxia Zhu,et al. Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in Fibroblasts , 2011, PloS one.
[41] Wei Shui,et al. SIRT1 protects against apoptosis by promoting autophagy in degenerative human disc nucleus pulposus cells , 2014, Scientific Reports.
[42] R. Kandel,et al. TNF-&agr; Induces MMP2 Gelatinase Activity and MT1-MMP Expression in an In Vitro Model of Nucleus Pulposus Tissue Degeneration , 2008, Spine.
[43] Xuqi Li,et al. SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment , 2015, FEBS letters.
[44] J. Jankovic,et al. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease , 2011, Neurosignals.
[45] P. Barnes,et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. , 2004, American journal of physiology. Lung cellular and molecular physiology.